Literature DB >> 16155063

Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy.

Joan L Robinson1, Gerda Tawfik, Lynora Saxinger, Linda Stang, Wai Etches, Bonita Lee.   

Abstract

OBJECTIVES: The purpose of this study was to determine the biological stability of heparin and to test for physical compatibility in heparin/antibiotic solutions in concentrations suitable for antibiotic lock therapy.
METHODS: Solutions were prepared with heparin 5000 U/mL or heparin 10 U/mL and cefazolin 10 mg/mL, ampicillin 10 mg/mL, or piperacillin 40 mg/mL. Solutions of vancomycin 2.5 mg/mL with heparin 5000 U/mL and vancomycin 2 mg/mL with heparin 10 U/mL were also prepared. The ability of each solution to elevate the activated partial thromboplastin time (APTT) of pooled normal plasma and the physical compatibility of the solutions were assessed for 14 days.
RESULTS: The APTT levels never varied by more than 16.4% from baseline. Physical incompatibility never occurred before day 14 in any of the solutions.
CONCLUSIONS: Mixing of antibiotics in the concentrations chosen for the study had no clinically significant effect on biological heparin activity, and all solutions were physically compatible for at least 14 days.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155063     DOI: 10.1093/jac/dki311

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin.

Authors:  A Soriano; E Bregada; J M Marqués; M Ortega; A Bové; J A Martínez; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

3.  Current strategies for the prevention and management of central line-associated bloodstream infections.

Authors:  Zhuolin Han; Stephen Y Liang; Jonas Marschall
Journal:  Infect Drug Resist       Date:  2010-11-23       Impact factor: 4.003

4.  Anticoagulant properties of enoxaparin 400 IU/mL-40 % ethanol catheter lock solution.

Authors:  Laure Calvet; Michèle Piot; Claire Lartigue; Bertrand Souweine; Brigitte Tardy-Poncet
Journal:  Springerplus       Date:  2015-12-01

Review 5.  Antibiotic lock therapy: review of technique and logistical challenges.

Authors:  Julie Ann Justo; P Brandon Bookstaver
Journal:  Infect Drug Resist       Date:  2014-12-12       Impact factor: 4.003

Review 6.  Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.

Authors:  Ondřej Kubeček; Pavla Paterová; Martina Novosadová
Journal:  Life (Basel)       Date:  2021-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.